Cargando…

Salivary miR-30c-5p as Potential Biomarker for Detection of Oral Squamous Cell Carcinoma

The levels of different classes of extracellular RNAs (exRNAs) remain stable in bodily fluids. The detection of either enriched or depleted specific subsets of salivary microRNAs (miRNAs) has the potential to serve as a non-invasive approach for biomarker development. Thus, salivary miRNAs have emer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mehterov, Nikolay, Vladimirov, Boyan, Sacconi, Andrea, Pulito, Claudio, Rucinski, Marcin, Blandino, Giovanni, Sarafian, Victoria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465705/ https://www.ncbi.nlm.nih.gov/pubmed/34572265 http://dx.doi.org/10.3390/biomedicines9091079

Ejemplares similares

A novel panel of clinically relevant miRNAs signature accurately differentiates oral cancer from normal mucosa
por: Mehterov, Nikolay, et al.
Publicado: (2022)

The lncRNAs/miR-30e/CHI3L1 Axis Is Dysregulated in Systemic Sclerosis
por: Dichev, Valentin, et al.
Publicado: (2022)

miRNAs in Lymphocytic Leukaemias—The miRror of Drug Resistance
por: Sbirkov, Yordan, et al.
Publicado: (2022)

Alternative RNA Splicing—The Trojan Horse of Cancer Cells in Chemotherapy
por: Mehterov, Nikolay, et al.
Publicado: (2021)

Long Non-coding MIR205HG Depletes Hsa-miR-590-3p Leading to Unrestrained Proliferation in Head and Neck Squamous Cell Carcinoma
por: Di Agostino, Silvia, et al.
Publicado: (2018)

Exploiting Long Non-Coding RNAs and Circular RNAs as Pharmacological Targets in Triple-Negative Breast Cancer Treatment
por: Palcau, Alina Catalina, et al.
Publicado: (2023)

Epigenetic methylation changes: implication as biomarkers in oral and maxillofacial area cancers
por: Aghiorghiesei, Ovidiu, et al.
Publicado: (2023)

Immunosignatures associated with TP53 status and co-mutations classify prognostically head and neck cancer patients
por: Sacconi, Andrea, et al.
Publicado: (2023)

Multitargeting activity of miR-24 inhibits long-term melatonin anticancer effects
por: Mori, Federica, et al.
Publicado: (2016)

miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma
por: Sestito, Rosanna, et al.
Publicado: (2015)

The miR-205-5p/BRCA1/RAD17 Axis Promotes Genomic Instability in Head and Neck Squamous Cell Carcinomas
por: Valenti, Fabio, et al.
Publicado: (2019)

Thymic Epithelial Tumors phenotype relies on miR-145-5p epigenetic regulation
por: Bellissimo, Teresa, et al.
Publicado: (2017)

miR-96-5p targets PTEN expression affecting radio-chemosensitivity of HNSCC cells
por: Vahabi, Mahrou, et al.
Publicado: (2019)

Dihydroartemisinin: from malaria to the treatment of relapsing head and neck cancers
por: Pulito, Claudio, et al.
Publicado: (2020)

Oral mucositis: the hidden side of cancer therapy
por: Pulito, Claudio, et al.
Publicado: (2020)

Autophagy and SARS-CoV-2-Old Players in New Games
por: Ivanova, Tsvetomira, et al.
Publicado: (2023)

Salivary miRNAs Expression in Potentially Malignant Disorders of the Oral Mucosa and Oral Squamous Cell Carcinoma: A Pilot Study on miR-21, miR-27b, and miR-181b
por: Di Stasio, Dario, et al.
Publicado: (2022)

Salivary miR-31-5p, miR-345-3p, and miR-424-3p Are Reliable Biomarkers in Patients with Oral Squamous Cell Carcinoma
por: Scholtz, Beáta, et al.
Publicado: (2022)

Targeting endothelin 1 receptor-miR-200b/c-ZEB1 circuitry blunts metastatic progression in ovarian cancer
por: Sestito, Rosanna, et al.
Publicado: (2020)

Salivary extracellular vesicle-associated miRNAs as potential biomarkers in oral squamous cell carcinoma
por: Gai, Chiara, et al.
Publicado: (2018)

Alcohol-dysregulated miR-30a and miR-934 in head and neck squamous cell carcinoma
por: Saad, Maarouf A., et al.
Publicado: (2015)

Metformin-induced metabolic reprogramming of chemoresistant ALDH(bright) breast cancer cells
por: Cioce, Mario, et al.
Publicado: (2014)

Epigenetic silencing of miR-296 and miR-512 ensures hTERT dependent apoptosis protection and telomere maintenance in basal-type breast cancer cells
por: Dinami, Roberto, et al.
Publicado: (2017)

miR-181c associates with tumor relapse of high grade osteosarcoma
por: Federica, Mori, et al.
Publicado: (2015)

HSF-1/miR-145-5p transcriptional axis enhances hyperthermic intraperitoneal chemotherapy efficacy on peritoneal ovarian carcinosis
por: Di Agostino, Silvia, et al.
Publicado: (2023)

Metformin: Metabolic Rewiring Faces Tumor Heterogeneity
por: Cioce, Mario, et al.
Publicado: (2020)

Metformin: On Ongoing Journey across Diabetes, Cancer Therapy and Prevention
por: Pulito, Claudio, et al.
Publicado: (2013)

Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma
por: Romani, Chiara, et al.
Publicado: (2021)

Cdx2 Polymorphism Affects the Activities of Vitamin D Receptor in Human Breast Cancer Cell Lines and Human Breast Carcinomas
por: Pulito, Claudio, et al.
Publicado: (2015)

Salivary biomarkers in oral squamous cell carcinoma
por: Nguyen, Truc Thi Hoang, et al.
Publicado: (2020)

Targeting a phospho-STAT3-miRNAs pathway improves vesicular hepatic steatosis in an in vitro and in vivo model
por: Belloni, Laura, et al.
Publicado: (2018)

CircPVT1: a pivotal circular node intersecting Long Non-Coding-PVT1 and c-MYC oncogenic signals
por: Palcau, Alina Catalina, et al.
Publicado: (2022)

miR-22-3p and miR-30e-5p Are Associated with Prognosis in Cervical Squamous Cell Carcinoma
por: Kwon, Ah-Young, et al.
Publicado: (2022)

Salivary Metabolomics for Prognosis of Oral Squamous Cell Carcinoma
por: Ishikawa, Shigeo, et al.
Publicado: (2022)

Salivary melatonin in oral squamous cell carcinoma patients
por: Salarić, Ivan, et al.
Publicado: (2021)

Aberrant transcriptional and post-transcriptional regulation of SPAG5, a YAP-TAZ-TEAD downstream effector, fuels breast cancer cell proliferation
por: Canu, Valeria, et al.
Publicado: (2020)

Exploiting salivary miR-375 as a clinical biomarker of oral potentially malignant disorder
por: Tu, Hsi-Feng, et al.
Publicado: (2022)

Serum miR-626 and miR-5100 are Promising Prognosis Predictors for Oral Squamous Cell Carcinoma
por: Shi, Jianbo, et al.
Publicado: (2019)

Upregulation of YKL-40 Promotes Metastatic Phenotype and Correlates with Poor Prognosis and Therapy Response in Patients with Colorectal Cancer
por: De Robertis, Mariangela, et al.
Publicado: (2022)

miR-155, miR-191, and miR-494 as diagnostic biomarkers for oral squamous cell carcinoma and the effects of Avastin on these biomarkers
por: Emami, Naghmeh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jjpgmelcejeqd4rpur38u89mob